RESUMO
Analytical Quality by Design principles using the design of experiments were applied for the development of a capillary electrophoresis method for the determination of enantiomeric purity and chemically related impurities of tamsulosin. From initial scouting experiments, a dual cyclodextrin (CD) system composed of sulfated ß-CD and carboxymethyl-α-CD was selected as the chiral selector. A fractional factorial resolution V+ design was used for the identification of the critical process parameters, while a face-centered central composite design and Monte Carlo simulations were employed for final optimization and defining the design space of the method. The experimental conditions of the working point were: 30 mM sodium phosphate buffer, pH 3.0, containing 40 mg/mL sulfated ß-CD and 7 mg/mL carboxymethyl-α-CD, capillary temperature 18°C, applied voltage -23 kV. Following the assessment of robustness by applying a Plackett-Burman design, the method was validated according to the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use guideline Q2(R1). The method allowed the quantification of the chiral impurity and three other related impurities at the 0.1 % level with acceptable accuracy and precision.
Assuntos
Ciclodextrinas , Eletroforese Capilar , Humanos , Tansulosina , Eletroforese Capilar/métodos , Projetos de Pesquisa , Estereoisomerismo , Reprodutibilidade dos TestesRESUMO
Capillary electrophoresis (CE) is a potent method for analyzing chiral substances and is commonly used in the enantioseparation and chiral purity control of pharmaceuticals from different matrices. The adoption of Quality by Design (QbD) concepts in analytical method development, optimization and validation is a widespread trend observed in various analytical approaches including chiral CE. The application of Analytical QbD (AQbD) leads to the development of analytical methods based on sound science combined with risk management, and to a well understood process clarifying the influence of method parameters on the analytical output. The Design of Experiments (DoE) method employing chemometric tools is an essential part of QbD-based method development, allowing for the simultaneous evaluation of experimental parameters as well as their interaction. In 2022 the International Council for Harmonization (ICH) released two draft guidelines (ICH Q14 and ICH Q2(R2)) that are intended to encourage more robust analytical procedures. The ICH Q14 guideline intends to harmonize the scientific approaches for analytical procedures' development, while the Q2(R2) document covers the validation principles for the use of analytical procedures including the recent applications that require multivariate statistical analyses. The aim of this review is to provide an overview of the new prospects for chiral CE method development applied for the enantiomeric purity control of pharmaceuticals using AQbD principles. The review also provides an overview of recent research (2012-2022) on the applicability of CE methods in chiral drug impurity profiling.
Assuntos
Contaminação de Medicamentos , Eletroforese Capilar , Estereoisomerismo , Eletroforese Capilar/métodos , Controle de Qualidade , Preparações FarmacêuticasRESUMO
Chirality is one of the major issues in pharmaceutical research and industry. Capillary electrophoresis (CE) is an interesting alternative to the more frequently used chromatographic techniques in the enantioseparation of pharmaceuticals, and is used for the determination of enantiomeric ratio, enantiomeric purity, and in pharmacokinetic studies. Traditionally, optimization of CE methods is performed using a univariate one factor at a time (OFAT) approach; however, this strategy does not allow for the evaluation of interactions between experimental factors, which may result in ineffective method development and optimization. In the last two decades, Design of Experiments (DoE) has been frequently employed to better understand the multidimensional effects and interactions of the input factors on the output responses of analytical CE methods. DoE can be divided into two types: screening and optimization designs. Furthermore, using Quality by Design (QbD) methodology to develop CE-based enantioselective techniques is becoming increasingly popular. The review presents the current use of DoE methodologies in CE-based enantioresolution method development and provides an overview of DoE applications in the optimization and validation of CE enantioselective procedures in the last 25 years. Moreover, a critical perspective on how different DoE strategies can aid in the optimization of enantioseparation procedures is presented.
Assuntos
Eletroforese Capilar/métodos , Preparações Farmacêuticas/química , Preparações Farmacêuticas/isolamento & purificação , Humanos , EstereoisomerismoRESUMO
Omeprazole (OME) is a proton pump inhibitor used to treat gastroesophageal reflux disease associated conditions. The current study presents an Analytical Quality by Design-based approach for the development of a CE method for OME impurity profiling. The scouting experiments suggested the selection of solvent modified Micellar ElectroKinetic Chromatography operative mode using a pseudostationary phase composed of sodium dodecyl sulfate (SDS) micelles and n-butanol as organic modifier in borate buffer. A symmetric three-level screening matrix 37//16 was used to evaluate the effect of Critical Method Parameters, including Background Electrolyte composition and instrumental settings, on Critical Method Attributes (critical resolution values, OME peak width and analysis time). The analytical procedure was optimized using Response Surface Methodology through a Central Composite Orthogonal Design. Risk of failure maps made it possible to define the Method Operable Design Region, within which the following optimized conditions were selected: 72â¯mM borate buffer pH 10.0, 96â¯mM SDS, 1.45â¯%v/v n-butanol, capillary temperature 21 °C, applied voltage 25â¯kV. The method was validated according to ICH guidelines and robustness was evaluated using a Plackett-Burman design. The developed procedure enables the simultaneous determination of OME and seven related impurities, and has been successfully applied to the analysis of pharmaceutical formulations.
Assuntos
Contaminação de Medicamentos , Eletroforese Capilar , Omeprazol , Inibidores da Bomba de Prótons , Dodecilsulfato de Sódio , Omeprazol/análise , Omeprazol/química , Contaminação de Medicamentos/prevenção & controle , Eletroforese Capilar/métodos , Inibidores da Bomba de Prótons/análise , Dodecilsulfato de Sódio/química , Reprodutibilidade dos Testes , Solventes/química , Cromatografia Capilar Eletrocinética Micelar/métodos , Concentração de Íons de Hidrogênio , Micelas , 1-Butanol/químicaRESUMO
Silodosin is a single isomer selective α1-adrenoreceptor antagonist used for the treatment of benign prostatic hyperplasia. In order to control the enantiomeric purity of the drug a capillary electrophoresis method was developed that is applicable to the analysis of drug substance as well as pharmaceutical formulations. Method development followed a quality by design strategy. After selection of carboxymethyl-ß-cyclodextrin as suitable chiral selector and the starting conditions in the scouting phase, a two-level full factorial design was applied to identify the critical process parameters. The final method optimization was performed using a face-centered central composite design resulting in the conditions 100 mM sodium phosphate buffer, pH 2.9, containing 40 mg/mL car-boxymethyl-ß-cyclodextrin, a capillary temperature of 17 °C and an applied voltage of 28 kV. Robustness testing employing a Plackett-Burman design revealed the importance of careful pH adjustment in order to achieve suitable peak shape and resolution. The method was validated according to the guideline Q2(R1) of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use and applied to the analysis of a commercial capsule formulation.
Assuntos
Ciclodextrinas , Eletroforese Capilar , Humanos , Eletroforese Capilar/métodos , Estereoisomerismo , Indóis , Ciclodextrinas/química , Concentração de Íons de HidrogênioRESUMO
Chirality of pharmaceutical substances is an important aspect in drug research because it determines how enantiomers will interact with chiral biological targets. Enantiomers of a chiral drug can have different pharmacokinetic and pharmacological profiles; consequently, using a single pure enantiomer instead of a racemate can enhance the effectiveness and/or safety of the treatment. The tendencies of modern pharmaceutical industry regarding the current market of chiral drugs are divided between the chiral switch of previously used racemates and the development of new enantiopure drugs. The term chiral switch refers to the replacement on the market of a previously approved racemate with its single enantiomer version. The potential advantages of chiral switch can be related to a higher therapeutic index due to better potency, selectivity and fewer adverse effects, faster onset of action and exposure of the patient to lower drug dosages. However, chiral switch is also a strategy that permits manufacturers to keep market exclusivity for chiral pharmaceuticals that have lost their patent protection, even if the pure enantiomers have not demonstrated higher effectiveness or safety profile compared with the racemates.
RESUMO
Vegetables can contain significant amounts of nitrate and, therefore, may pose health hazards to consumers by exceeding the accepted daily intake for nitrate. Different hydroponic growing patterns were examined in this work in order to obtain 'nitrate-free lettuces'. Growing lettuces on low nitrate content nutrient solution resulted in a significant decrease in lettuces' nitrate concentrations (1741 versus 39 mg kg(-1)), however the beneficial effect was cancelled out by an increase in the ambient temperature. Nitrate replacement with ammonium was associated with an important decrease of the lettuces' nitrate concentration (from 1896 to 14 mg kg(-1)) and survival rate. An economically feasible method to reduce nitrate concentrations was the removal of all inorganic nitrogen from the nutrient solution before the exponential growth phase. This method led to lettuces almost devoid of nitrate (10 mg kg(-1)). The dried mass and calcinated mass of lettuces, used as markers of lettuces' quality, were not influenced by this treatment, but a small reduction (18%, p < 0.05) in the fresh mass was recorded. The concentrations of nitrite in the lettuces and their modifications are also discussed in the paper. It is possible to obtain 'nitrate-free' lettuces in an economically feasible way.